Published in
Wiley Open Access, Cancer Medicine, 9(5), p. 2232-2239, 2016
DOI: 10.1002/cam4.803
Links
Tools
New schedule of bevacizumab/paclitaxel as first-line therapy for metastatic HER2-negative breast cancer in a real-life setting
Journal article published in 2016 by
Katia Cannita,
Stefania Paradisi,
Valentina Cocciolone,
Alberto Bafile,
Lucia Rinaldi,
Azzurra Irelli 
,
Paola Lanfiuti Baldi,
Luigi Zugaro,
Rosa Manetta,
Edoardo Alesse,
Enrico Ricevuto,
Corrado Ficorella
,
Paola Lanfiuti Baldi,
Luigi Zugaro,
Rosa Manetta,
Edoardo Alesse,
Enrico Ricevuto,
Corrado Ficorella
This paper is made freely available by the publisher.
Full text: Download
Data provided by 